Accounting for correlation in network meta-analysis with multi-arm trials

被引:61
作者
Franchini, A. J. [1 ]
Dias, S. [1 ]
Ades, A. E. [1 ]
Jansen, J. P. [2 ,3 ]
Welton, N. J. [1 ]
机构
[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England
[2] Mapi Grp, Boston, MA 02114 USA
[3] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
基金
英国医学研究理事会;
关键词
meta-analysis; mixed treatment comparison; multiple treatment comparison; network meta-analysis; DOUBLE-BLIND; PARKINSONS-DISEASE; META-REGRESSION; PRAMIPEXOLE; MULTICENTER; ROPINIROLE; PLACEBO; MODEL;
D O I
10.1002/jrsm.1049
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multi-arm trials (trials with more than two arms) are particularly valuable forms of evidence for network meta-analysis (NMA). Trial results are available either as arm-level summaries, where effect measures are reported for each arm, or as contrast-level summaries, where the differences in effect between arms compare with the control arm chosen for the trial. We show that likelihood-based inference in both contrast-level and arm-level formats is identical if there are only two-arm trials, but that if there are multi-arm trials, results from the contrast-level format will be incorrect unless correlations are accounted for in the likelihood. We review Bayesian and frequentist software for NMA with multi-arm trials that can account for this correlation and give an illustrative example of the difference in estimates that can be introduced if the correlations are not incorporated. We discuss methods of imputing correlations when they cannot be derived from the reported results and urge trialists to report the standard error for the control arm even if only contrast-level summaries are reported. Copyright (C) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:142 / 160
页数:19
相关论文
共 34 条
[1]  
[Anonymous], 2016, NICE DSU technical support document 4: inconsistency in networks of evidence based on randomised controlled trials
[2]  
[Anonymous], 1985, Statistical method for meta-analysis
[3]   General methods for monitoring convergence of iterative simulations [J].
Brooks, SP ;
Gelman, A .
JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS, 1998, 7 (04) :434-455
[4]   A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa [J].
Brunt, ER ;
Brooks, DJ ;
Korczyn, AD ;
Montastruc, JL ;
Stocchi, F .
JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (04) :489-502
[5]  
Dakin H, 2011, MIXED TREATMEN UNPUB
[6]  
Gelman A, 1996, MARKOV CHAIN MONTE C, P131
[7]  
Gershanik O, 1994, 40A FARM CARL ERB
[8]  
Gershanik O, 1994, 41B FARM CARL ERB
[9]   Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease [J].
Guttman, M ;
Ott, E ;
Tragner, H ;
Bedard, PJ ;
Pourcher, E ;
Curran, T ;
Goodridge, A ;
Guttman, M ;
Hobson, D ;
King, D ;
Martin, WRW ;
Mendis, T ;
Rajput, A ;
Rivest, J ;
Stoessl, J ;
Suchowersky, O ;
Moran, J ;
Murphy, R ;
Walsh, B ;
ONeill, DO ;
Klemperer, B ;
Martin, M ;
Oehlwein, C ;
Polzer, U ;
Reichmann, H ;
Schimek, J ;
Schlenker, M ;
Schwartz, A ;
Meier, D ;
Traubner, P ;
Benetin, J ;
Bomhof, MAM ;
Hovestadt, A ;
Vreeling, FW ;
Wolters, ECMJ ;
Broddie, HG ;
Clarke, C ;
Clough, CJ ;
Loizou, L ;
Newman, PK ;
Pye, IF .
NEUROLOGY, 1997, 49 (04) :1060-1065
[10]   Robust variance estimation in meta-regression with dependent effect size estimates [J].
Hedges, Larry V. ;
Tipton, Elizabeth ;
Johnson, Matthew C. .
RESEARCH SYNTHESIS METHODS, 2010, 1 (01) :39-65